vs
DYNAVAX TECHNOLOGIES CORP（DVAX）与Netskope Inc（NTSK）财务数据对比。点击上方公司名可切换其他公司
Netskope Inc的季度营收约是DYNAVAX TECHNOLOGIES CORP的1.9倍（$184.2M vs $94.9M），DYNAVAX TECHNOLOGIES CORP净利率更高（28.4% vs -246.0%，领先274.4%），DYNAVAX TECHNOLOGIES CORP自由现金流更多（$32.6M vs $10.4M）
Dynavax Technologies Corp是一家处于商业化阶段的生物制药企业，专注于研发和生产针对传染病的创新疫苗及免疫疗法，核心上市产品为成人乙肝疫苗Heplisav-B，主要市场覆盖北美与欧洲，同时拥有多款针对未满足公共卫生需求的在研产品。
Netskope是全球领先的网络安全企业，主打安全访问服务边缘（SASE）解决方案、云安全平台与零信任架构工具，服务覆盖北美、欧洲、亚太地区的企业客户，助力各类机构保障远程办公环境、云应用与数字资产的安全。
DVAX vs NTSK — 直观对比
营收规模更大
NTSK
是对方的1.9倍
$94.9M
净利率更高
DVAX
高出274.4%
-246.0%
自由现金流更多
DVAX
多$22.2M
$10.4M
损益表 — Q3 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $94.9M | $184.2M |
| 净利润 | $26.9M | $-453.1M |
| 毛利率 | — | 57.9% |
| 营业利润率 | 22.4% | -242.7% |
| 净利率 | 28.4% | -246.0% |
| 营收同比 | 17.7% | — |
| 净利润同比 | 53.0% | -401.7% |
| 每股收益（稀释后） | $0.21 | $-1.85 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DVAXNTSK
| Q4 25 | — | $184.2M | ||
| Q3 25 | $94.9M | — | ||
| Q2 25 | $95.4M | — | ||
| Q1 25 | $68.2M | — | ||
| Q4 24 | $72.0M | — | ||
| Q3 24 | $80.6M | — | ||
| Q2 24 | $73.8M | — | ||
| Q1 24 | $50.8M | — |
净利润DVAXNTSK
| Q4 25 | — | $-453.1M | ||
| Q3 25 | $26.9M | — | ||
| Q2 25 | $18.7M | — | ||
| Q1 25 | $-96.1M | — | ||
| Q4 24 | $7.0M | — | ||
| Q3 24 | $17.6M | — | ||
| Q2 24 | $11.4M | — | ||
| Q1 24 | $-8.7M | — |
毛利率DVAXNTSK
| Q4 25 | — | 57.9% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率DVAXNTSK
| Q4 25 | — | -242.7% | ||
| Q3 25 | 22.4% | — | ||
| Q2 25 | 15.1% | — | ||
| Q1 25 | -34.7% | — | ||
| Q4 24 | -2.3% | — | ||
| Q3 24 | 12.5% | — | ||
| Q2 24 | 7.0% | — | ||
| Q1 24 | -35.0% | — |
净利率DVAXNTSK
| Q4 25 | — | -246.0% | ||
| Q3 25 | 28.4% | — | ||
| Q2 25 | 19.6% | — | ||
| Q1 25 | -141.0% | — | ||
| Q4 24 | 9.8% | — | ||
| Q3 24 | 21.8% | — | ||
| Q2 24 | 15.4% | — | ||
| Q1 24 | -17.2% | — |
每股收益（稀释后）DVAXNTSK
| Q4 25 | — | $-1.85 | ||
| Q3 25 | $0.21 | — | ||
| Q2 25 | $0.14 | — | ||
| Q1 25 | $-0.77 | — | ||
| Q4 24 | $0.07 | — | ||
| Q3 24 | $0.12 | — | ||
| Q2 24 | $0.08 | — | ||
| Q1 24 | $-0.07 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $160.2M | $1.2B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $534.1M | $151.0M |
| 总资产 | $946.5M | $1.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DVAXNTSK
| Q4 25 | — | $1.2B | ||
| Q3 25 | $160.2M | — | ||
| Q2 25 | $99.1M | — | ||
| Q1 25 | $51.7M | — | ||
| Q4 24 | $95.9M | — | ||
| Q3 24 | $119.3M | — | ||
| Q2 24 | $112.5M | — | ||
| Q1 24 | $132.0M | — |
股东权益DVAXNTSK
| Q4 25 | — | $151.0M | ||
| Q3 25 | $534.1M | — | ||
| Q2 25 | $494.2M | — | ||
| Q1 25 | $530.9M | — | ||
| Q4 24 | $596.8M | — | ||
| Q3 24 | $681.4M | — | ||
| Q2 24 | $642.8M | — | ||
| Q1 24 | $618.5M | — |
总资产DVAXNTSK
| Q4 25 | — | $1.7B | ||
| Q3 25 | $946.5M | — | ||
| Q2 25 | $918.4M | — | ||
| Q1 25 | $945.9M | — | ||
| Q4 24 | $986.3M | — | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $1.0B | — | ||
| Q1 24 | $986.6M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $33.8M | $19.9M |
| 自由现金流经营现金流 - 资本支出 | $32.6M | $10.4M |
| 自由现金流率自由现金流/营收 | 34.4% | 5.6% |
| 资本支出强度资本支出/营收 | 1.3% | 5.2% |
| 现金转化率经营现金流/净利润 | 1.26× | — |
| 过去12个月自由现金流最近4个季度 | $80.5M | — |
8季度趋势，按日历期对齐
经营现金流DVAXNTSK
| Q4 25 | — | $19.9M | ||
| Q3 25 | $33.8M | — | ||
| Q2 25 | $23.4M | — | ||
| Q1 25 | $-19.6M | — | ||
| Q4 24 | $53.0M | — | ||
| Q3 24 | $19.5M | — | ||
| Q2 24 | $10.7M | — | ||
| Q1 24 | $-16.7M | — |
自由现金流DVAXNTSK
| Q4 25 | — | $10.4M | ||
| Q3 25 | $32.6M | — | ||
| Q2 25 | $22.0M | — | ||
| Q1 25 | $-23.6M | — | ||
| Q4 24 | $49.5M | — | ||
| Q3 24 | $18.1M | — | ||
| Q2 24 | $9.9M | — | ||
| Q1 24 | $-17.4M | — |
自由现金流率DVAXNTSK
| Q4 25 | — | 5.6% | ||
| Q3 25 | 34.4% | — | ||
| Q2 25 | 23.0% | — | ||
| Q1 25 | -34.6% | — | ||
| Q4 24 | 68.8% | — | ||
| Q3 24 | 22.5% | — | ||
| Q2 24 | 13.5% | — | ||
| Q1 24 | -34.3% | — |
资本支出强度DVAXNTSK
| Q4 25 | — | 5.2% | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 1.5% | — | ||
| Q1 25 | 5.8% | — | ||
| Q4 24 | 4.8% | — | ||
| Q3 24 | 1.7% | — | ||
| Q2 24 | 1.1% | — | ||
| Q1 24 | 1.5% | — |
现金转化率DVAXNTSK
| Q4 25 | — | — | ||
| Q3 25 | 1.26× | — | ||
| Q2 25 | 1.25× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 7.52× | — | ||
| Q3 24 | 1.11× | — | ||
| Q2 24 | 0.94× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DVAX
| HEPLISAVB | $90.0M | 95% |
| US Department Of Defense | $4.7M | 5% |
NTSK
| Indirect Channels | $175.2M | 95% |
| Direct End Customers | $8.9M | 5% |
